转录组与蛋白质组分析基于疾病活动度、结构损伤和影像学进展对中轴型脊柱关节炎患者进行分层
该研究纳入144例中轴型脊柱关节炎(axSpA)患者,通过对24例外周血单个核细胞RNA测序、60例微流控PCR验证及60例独立队列血清蛋白质组分析,结合机器学习,识别出与影像学损伤相关的分子通路,并发现由两个基因和基线mSASSS组成的预测模型可识别中快速影像学进展者。
要点
- 转录组无监督聚类可将axSpA分为两组,第2组疾病活动度更高、功能受损更重且结构损伤更多。
- WGCNA识别出6个在两组间差异表达的基因模块。
- 由两个基因和基线mSASSS组成的预测模型是识别中快速影像学进展的关键生物标志物。
核心结论
- 研究识别了参与axSpA影像学损伤的分子通路,并发现了疾病严重程度的潜在蛋白质组生物标志物及影像学进展的转录组预测因子。
研究设计与样本
- 共纳入144例axSpA患者,对24例患者的外周血单个核细胞RNA进行测序,在60例验证队列中通过微流控PCR检测核心基因。
- 通过5年随访将患者分类为快速/中速或缓慢进展者,应用机器学习整合基因表达数据与临床变量以识别进展预测生物标志物。
- 一个独立的60例axSpA患者队列(5年前有脊柱X线片)接受血清蛋白质组分析,使用邻位延伸分析技术。
主要发现
- 转录组无监督聚类分析揭示两个不同的axSpA患者组,其临床特征存在差异。
- 加权基因共表达网络分析识别出两个聚类间差异表达的6个基因模块。
- 第2聚类患者表现出更高的疾病活动度、更重的功能损害和更多的结构损伤。
- 与结构损伤相关的分子改变揭示了与疾病严重程度相关的特定循环炎症蛋白质组谱。
- 由两个基因和基线总改良Stoke强直性脊柱炎脊柱评分(mSASSS)组成的预测模型成为识别中快速影像学进展的关键生物标志物。
临床怎么用
- 对于axSpA患者,可考虑基于转录组聚类分层以识别疾病活动度高、功能损害重和结构损伤多的患者。
- 由两个基因和基线mSASSS组成的预测模型可能有助于识别中快速影像学进展者,但需进一步验证。
- 血清蛋白质组谱可能作为评估疾病严重程度的潜在生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify clusters of highly correlated genes enriched in biological functions and specific molecular pathways involved in the pathogenesis of radiographic damage in axial spondyloarthritis (axSpA) and to discover molecular biomarkers of radiographic progression and disease severity. METHODS: A total of 144 patients with axSpA were included. First, RNA from peripheral blood mononuclear cells was sequenced in a cohort of 24 patients with axSpA. Hub genes were measured in a n=60 validation cohort through microfluidic PCR. A 5-year follow-up enabled the classification of the patients into fast/moderate or slow progressors. Machine learning approaches were applied to identify a predictive biomarker of progression by integrating gene expression data with clinical variables. An independent cohort of 60 patients with axSpA, with spine radiographs taken 5 years prior, underwent serum proteomic analysis using a Proximity Extension Assay. RESULTS: Unsupervised clustering analysis using transcriptomics revealed two distinct groups of patients with axSpA, differentiated by their clinical profiles. Weight gene correlation network analysis identified six gene modules differentially expressed between the two clusters. Patients in cluster 2 exhibited higher disease activity, greater functional impairment and more structural damage. Molecular alterations linked to structural damage revealed a specific circulating inflammatory proteome profile associated with disease severity. A predictive model composed of two genes and basal total modified Stoke Ankylosing Spondylitis Spinal Score emerged as a key biomarker for identifying moderate-to-fast radiographic progression. CONCLUSIONS: This study identified molecular pathways involved in radiographic damage and discovered potential proteomic biomarkers of disease severity and transcriptomic predictors of radiographic progression in axSpA.
引用
- Cuesta-López L, Arias-de la Rosa I, Pérez-Sánchez C, et al. Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression. RMD Open. 2026. PMID: 41592912. doi:10.1136/rmdopen-2025-006136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。